DataMeds AI, Inc. (MEDS) stock
Close on Nov 13, 2026Market cap $2.28MP/E –Yield –
DataMeds AI, Inc. saw revenue fall 77.5% to $7.68M over the twelve months to Sep 30, 2026. At the latest close the market valued the company at $2.28M.
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Sep 30, 2026
Valuation
- Market cap
- $2.28M
- P/E ratio
- –
- Price to sales
- 0.30
- Price to book
- –
- Dividend yield
- –
- Free cash flow yield
- –
Fundamentals
- Revenue
- $7.68M
- Net income
- -$43.37M
- EPS, diluted
- -$22.33
- Book value per share
- -$0.43
- Diluted shares
- 4M
Trading
- Previous close
- $0.87
- Open
- $0.87
- Day's range
- $0.55 – $1.09
- Volume
- 5,938,834
- Average volume (20 days)
- 834,692
- 52-week range
- $0.55 – $35.50
- RSI (14 days)
- 26.4
- Volatility (1 year)
- 338.4%
- Relative volume
- 1.27×
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 13, 2026. The S&P 500 is measured by the SPY fund.
| Period | MEDS | S&P 500 | Difference | MEDS per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | -75.4% | -3.0% | −72.4 pts | ||
| 3 months | -50.1% | -2.8% | −47.3 pts | ||
| Year to date | -96.3% | +11.5% | −107.8 pts | ||
| 1 year | -97.3% | +13.5% | −110.8 pts |
Four years at a glance
Fiscal years 2022 to 2025 and trailing twelve months, USD
Revenue
Gross profit
Operating income
Net income
EPS, diluted
Press releases
Releases DataMeds AI filed with the SEC as exhibits to Form 8-K or 6-K
- Results
- Update
- Update
- Update
- Update
- Results
About DataMeds AI
Wholesale-Drugs, Proprietaries & Druggists' Sundries
Wellgistics Health, Inc. operates as a healthcare and pharmaceutical holding company providing integrated solutions across dispensing, delivery, care coordination, and clinical management. Its business model spans three primary operating segments: a retail specialty pharmacy, pharmaceutical wholesale operations, and a technology division. The company's offerings include distribution of specialty-lite and maintenance medications, clinical concierge support, and digital prescription transfer services. Wellgistics serves individual patients, independent pharmacies, healthcare providers, pharmaceutical manufacturers, and health payors.
Company profile, executives and historyDataMeds AI stock: common questions
What is DataMeds AI's stock price?
MEDS closed at $0.74 on Nov 13, 2026, down 14.51% on the day. Over the past 52 weeks it traded between $0.55 and $35.50.
What is DataMeds AI's market cap?
DataMeds AI was worth $2.28M at the close on Nov 13, 2026: the share price times the diluted shares outstanding.
What is MEDS's P/E ratio?
DataMeds AI lost money over the twelve months to Sep 30, 2026 (diluted EPS -$22.33), so it has no meaningful P/E ratio.
How much revenue does DataMeds AI make?
DataMeds AI reported revenue of $7.68M for the twelve months to Sep 30, 2026, down 77.5% from a year earlier.
Does DataMeds AI pay a dividend?
No. DataMeds AI has not paid a cash dividend over the last twelve months.
How has MEDS stock performed over the past year?
Including dividends, MEDS returned -97.3% over the past year, against +13.5% for the S&P 500.
Who are DataMeds AI's competitors?
Companies most similar to DataMeds AI by business, industry and size include HKPD, STEK, COSM, PMHS, MNDR.
See a number that looks wrong?